Literature DB >> 1429727

Immunoglobulin kappa gene enhancers synergistically activate gene expression but independently determine chromatin structure.

V C Blasquez1, M A Hale, K W Trevorrow, W T Garrard.   

Abstract

Previous studies have located transcriptional enhancer elements within both the intron and 3'-region of the mouse kappa immunoglobulin gene. Here we address the role of these two enhancers in specifying gene activity and specific chromatin structures. MOPC41 kappa gene constructs, either intact or containing deletions of one or both enhancers, were introduced into S194 mouse plasmacytoma cells for transient and stable expression studies. Transient expression assays revealed that the basal level expression exhibited by enhancerless constructs was activated 100-200-fold by the two enhancers together in a synergistic fashion. A similar trend was observed when both enhancers were present in stably integrated constructs, although the synergy was less pronounced. Analysis of DNase I hypersensitive sites in the chromatin revealed that stably integrated constructs established hypersensitive sites about the enhancer sequences. These sites demonstrated the same nuclease susceptibility as those associated with the endogenous gene(s), and their establishment was independent of the presence of the other enhancer. Thus, although both enhancers are required for maximal gene expression, the elements act independently in determining specific chromatin structures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429727

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.

Authors:  Barbara S Nikolajczyk; Sylvia H Sardi; Joseph R Tumang; Lisa M Ganley-Leal
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

2.  Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.

Authors:  Zhe Liu; William T Garrard
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.

Authors:  R Fulton; B Van Ness
Journal:  Nucleic Acids Res       Date:  1993-10-25       Impact factor: 16.971

4.  Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.

Authors:  R Fulton; B van Ness
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

5.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  Divergent roles of RelA and c-Rel in establishing chromosomal loops upon activation of the Igkappa gene.

Authors:  Zhe Liu; Zhenyi Ma; Lance S Terada; William T Garrard
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

7.  EMERGE: a flexible modelling framework to predict genomic regulatory elements from genomic signatures.

Authors:  Karel van Duijvenboden; Bouke A de Boer; Nicolas Capon; Jan M Ruijter; Vincent M Christoffels
Journal:  Nucleic Acids Res       Date:  2015-11-03       Impact factor: 16.971

8.  Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers.

Authors:  Julia B Carleton; Kristofer C Berrett; Jason Gertz
Journal:  Cell Syst       Date:  2017-09-27       Impact factor: 10.304

9.  Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions.

Authors:  Mingyang Cai; Fan Gao; Peilin Zhang; Woojin An; Jiandang Shi; Kai Wang; Wange Lu
Journal:  Sci Rep       Date:  2015-10-05       Impact factor: 4.379

10.  Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.

Authors:  A Polack; R Feederle; G Klobeck; K Hörtnagel
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.